Diana Isaacs, ADCES 2022: Diabetes technology update and impact on time in range
It’s an exciting time in diabetes with several technologies available on the horizon. Advances in technology offer new choices for insulin pumps, connected “smart” pens, continuous glucose monitors (CGM) and automated insulin delivery systems. In this touchENDOCRINOLOGY interview, Dr Diana Isaacs (Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, Cleveland, OH, USA) discusses these technologies and explores how they have shown dramatic effects on glycaemic management and time in range.
The abstract entitled: ‘Diabetes Technology Update and Impact on Time in Range‘ was presented at the Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, 12-15 Aug, 2022.
- Why is time in range so important in diabetes management? (0:15)
- Could you give us a brief overview of the latest advances in insulin pumps, connected “smart” pens, continuous glucose monitors and automated insulin delivery systems? (1:18)
- What clinical evidence supports the use of these new technologies? (4:44)
- How can we optimise the use of these technologies to maximise the impact on timein range? (5:43)
Disclosures: Diana Isaacs is a consultant for Eli Lilly, and Sanofi; and is a speaker’s bureau participant for Dexcom, Abbott, Bayer, Insulet, Medtronic, Cequr, and Novo Nordisk.
Support: Interview supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Recorded as a highlight of ADCES 2022
Click here for more related content.
Share this Video
Related Videos In Diabetes
Chantal Mathieu: Research highlights from 2022 in diabetes
2022 saw the FDA approval of teplizumab to delay the onset of type 1 diabetes. In addition, there has also been evidence to suggest the effectivness of SGLT2 inhibitors in type 1 diabetes. We were delighted to speak with our editorial board member Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) around this year’s research […]
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!